Icyo Alirocumab ari cyo: Ibyo ikoreshwa, urugero rwo kuyifata, ingaruka zayo n'ibindi

Alirocumab ni umuti wandikirwa na muganga ufasha kugabanya urugero rwa kolesteroli mu maraso yawe igihe imirire n'imyitozo bidahagije. Ni igikoresho gikomeye gikora mu buryo butandukanye n'imiti isanzwe ya kolesteroli nka statins, gitanga icyizere ku bantu bakeneye ubufasha bwihariye mu gucunga ubuzima bw'umutima wabo.

Uyu muti ubarirwa mu cyiciro gishya cy'imiti yitwa PCSK9 inhibitors, kandi uza mu buryo bwo guterwa inshinge wowe ubwawe mu ruhu. Nubwo igitekerezo cyo kwiterera inshinge wenyine gishobora gutera ubwoba mu ntangiriro, abantu benshi basanga bibaye igice cyoroshye cy'ubuzima bwabo bwa buri munsi bahawe ubuyobozi bukwiriye n'ikipe y'abaganga babo.

Alirocumab ni iki?

Alirocumab ni umuti ukorwa n'abantu ugamije kurwanya poroteyine yihariye mu mubiri wawe yitwa PCSK9. Tekereza nk'umufasha wihariye ukorana n'umwijima wawe kugira ngo ukuremo kolesteroli nyinshi mu maraso yawe.

Bitandukanye na statins zikora imbere mu ngirangingo z'umwijima wawe, alirocumab ikora hanze y'izo ngirangingo mu kubuza poroteyine ya PCSK9. Iyi poroteyine isanzwe ibuza umwijima wawe gukuramo kolesteroli neza. Iyo alirocumab iyibuza, umwijima wawe ushobora gukora akazi keza cyane ko gukuramo kolesteroli mbi ya LDL mu maraso yawe.

Uyu muti uza mu buryo bw'umuti usobanutse, udafite ibara mu gakoresho kateguwe cyangwa urushinge. Ugenewe guterwa munsi y'uruhu, bivuze ko uyitera mu gice cy'ibinure munsi y'uruhu rwawe, kimwe n'uko abantu barwaye diyabete batera insuline.

Alirocumab ikoreshwa mu iki?

Alirocumab ikoreshwa cyane cyane mu kugabanya kolesteroli ya LDL (kolesteroli mbi) mu bantu bakuru bakeneye ubufasha bwihariye uretse imirire, imyitozo, n'indi miti ya kolesteroli. Muganga wawe ashobora kuyikwandikira niba ufite hypercholesterolemia yo mu muryango, indwara ya genetike itera urugero rwo hejuru rwa kolesteroli.

Bikoreshwa kandi ku bantu bafite indwara z'umutima zizwi kandi bakeneye kugabanya ibyago byo guhura n'ibitero by'umutima, stroke, cyangwa izindi ndwara zikomeye z'umutima. Ibi bikubiyemo abarwayi bamaze kugira ibitero by'umutima, stroke, cyangwa ubwoko runaka bw'ububabare bwo mu gituza bita angina itajegajega.

Uyu muti akenshi ugenewe abantu bataragera ku ntego zabo za cholesterol bakoresheje imiti ya statin yihanganirwa cyane. Abantu bamwe ntibashobora gufata statins kubera ingaruka z'uruhande nk'ububabare bw'imitsi, kandi alirocumab itanga inzira yindi yo kugenzura neza cholesterol.

Alirocumab ikora ite?

Alirocumab ifatwa nk'umuti ukomeye ugabanya cholesterol ukora ukoresheje uburyo buhanitse. Ni umubiri w'umubiri umwe wihariye ugamije kandi ukifatanya na poroteyine ya PCSK9 mu maraso yawe.

Ubu ni uburyo bifasha umubiri wawe: Umwijima wawe ufite ibyitabo bidasanzwe bifata cholesterol mu maraso yawe hanyuma bakayisenya. Poroteyine ya PCSK9 ikora nk'umuntu utera akavuyo, ikangiza ibi byitabo bifasha. Iyo alirocumab yugarije PCSK9, ibyitabo byinshi birarokoka kandi birashobora gukomeza gukuraho cholesterol mu maraso yawe.

Ubu buryo burashobora kugabanya cholesterol yawe ya LDL kuva kuri 45-60% cyangwa ndetse no hejuru y'ibyo ku bantu bamwe. Ibyo bikorwa birakomeye cyane kandi birashobora kugaragara mu byumweru bike utangiye kuvurwa. Bitandukanye n'imiti imwe ikora buhoro buhoro, alirocumab itanga kugabanya cholesterol vuba kandi bikomeye.

Nkwiriye gufata alirocumab nte?

Alirocumab itangwa nk'urushinge munsi y'uruhu rwawe buri byumweru bibiri. Urutonde rusanzwe ni 75 mg, nubwo muganga wawe ashobora kuyongera kuri 150 mg niba bibaye ngombwa. Uzayiterera mu itako ryawe, ukuboko kwo hejuru, cyangwa mu nda, uhinduranya aho utera inshinge kugirango wirinde kurakara kw'uruhu.

Uyu muti ushobora kuwufata urya cyangwa utarya kuko uterwa mu nshinge aho kumira. Ariko, ni ngombwa ko umuti ugera ku bushyuhe busanzwe mbere yo kuwutera. Uvane muri firigo iminota 15-40 mbere y'igihe cyo kwitera inshinge.

Umuvuzi wawe azakwigisha uburyo bwo kwitera inshinge neza mu gihe cyo gusura kwawe kwa mbere. Ikaramu yuzuye ituma iki gikorwa kigenda neza, ariko imyitozo ikwiriye ituma wumva umeze neza kandi ufite icyizere mu gihe cyo kwitera inshinge. Abantu benshi babona ko bifasha gushyiraho umunsi n'igihe bisanzwe byo kwitera inshinge kugira ngo bagumane umurongo umwe.

Nzamara Igihe Kingana Giki Ndafatwa Alirocumab?

Alirocumab akenshi ni umuti ufashwa igihe kirekire uzakomeza gufata igihe cyose ufasha urugero rwa kolesteroli yawe kandi muganga wawe abikugiriye inama. Abantu benshi bawufata imyaka aho gufata amezi, kuko kolesteroli nyinshi akenshi ni indwara idakira isaba gukomeza kuyivura.

Muganga wawe azagenzura urugero rwa kolesteroli yawe buri gihe, akenshi abisuzuma nyuma y'ibyumweru 4-8 byo kuvurwa hanyuma buri mezi make. Ibi bizami bifasha kumenya niba umuti ukora neza kandi niba hariho guhindura urugero bisabwa.

Igihe cyo kuvurwa giterwa n'uko ubuzima bwawe bumeze, harimo urugero rwa kolesteroli yawe, ibyago byo kurwara umutima, n'uburyo witwara ku muti. Abantu bamwe bashobora kugabanya urugero rwabo uko igihe kigenda, mu gihe abandi bashobora gukenera gukomeza gahunda imwe itagira iherezo.

Ni Ibihe Bikorwa Bigaragara Byatewe na Alirocumab?

Abantu benshi bafata alirocumab neza, ariko nk'imiti yose, ishobora gutera ibikorwa bigaragara. Ibikorwa bigaragara cyane akenshi biroroshye kandi bishobora gucungwa neza hamwe n'ubuvuzi bukwiye no kugenzura.

Dore ibikorwa bigaragara cyane ushobora guhura nabyo:

• Ibimenyetso byo ku gice cyateweho urushinge nk'ubutukura, kubyimba, cyangwa kubabara
• Ibimenyetso bisa n'ibikonjo birimo amazuru yiruka cyangwa umuhogo urya
• Ibimenyetso bisa n'ibicurane nk'umunaniro cyangwa kubabara imitsi
• Uruhumekero cyangwa amabara ku ruhu
• Uburwayi bw'inkari
• Impiswi cyangwa kuribwa mu nda

Ibi bimenyetso bigenda bikira uko umubiri wawe ukimenyera umuti. Guhinduranya aho utera urushinge no gukoresha uburyo bwiza bwo guteramo urushinge bishobora gufasha kugabanya ibimenyetso byo ku ruhu.

Nubwo bitajyenda bibaho kenshi, abantu bamwe bashobora kugira ibimenyetso bikomeye bisaba ubufasha bwihuse bw'abaganga:

• Urugero rukomeye rw'uburwayi bw'umubiri burimo guhumeka nabi, kubyimba mu maso cyangwa mu muhogo
• Kubabara imitsi cyangwa kunanirwa bidahoraho
• Ibimenyetso by'ibibazo by'umwijima nk'uruhu cyangwa amaso y'umuhondo
• Ibimenyetso bikomeye byo ku gice cyateweho urushinge bitagenda bikira

Vugana n'umuganga wawe niba ugize ibimenyetso bibangamiye cyangwa niba ibimenyetso bigutera imbogamizi mu buzima bwawe bwa buri munsi.

Ninde utagomba gufata Alirocumab?

Alirocumab ntabwo ikwiriye kuri buri wese, kandi muganga wawe azasuzuma neza niba ikwiriye kuri wowe. Abantu bafite allergie zizwi kuri alirocumab cyangwa ibindi bigize umuti bagomba kwirinda uyu muti.

Muganga wawe azitonda cyane niba ufite amateka y'uburwayi bukomeye bw'umubiri ku yindi miti cyangwa niba ufite indwara zimwe na zimwe. Abagore batwite ntibagomba gufata alirocumab keretse inyungu zishoboka zigaragaza neza ko zirenze ibyago, kuko ingaruka zayo ku bana bakiri mu nda ntizizwi neza.

Niba uri konka, biganireho na muganga wawe, kuko ntibizwi neza niba umuti ujya mu mata y'umugore. Abantu bafite indwara zikomeye z'impyiko cyangwa umwijima bashobora gukenera gukurikiranwa byihariye cyangwa guhindurirwa urugero rw'umuti.

Abana n'ingimbi muri rusange ntibagomba gufata alirocumab keretse bafite indwara ikomeye y'umuryango ya hypercholesterolemia kandi izindi nshuti zitagize icyo zikora. Umutekano n'imikorere ku barwayi b'abana biracyigwa.

Amazina y'ubwoko bwa Alirocumab

Alirocumab igurishwa ku izina rya Praluent muri Leta Zunze Ubumwe z'Amerika no mu bindi bihugu byinshi. Iri ni ryo zina risanzwe ubona ku mpapuro zandikirwa n'abaganga no mu ma farumasi.

Uyu muti ukorwa na Regeneron Pharmaceuticals na Sanofi, kandi uboneka gusa nk'umuti w'izina ry'ubwoko. Kugeza ubu, nta verisiyo rusange ya alirocumab iboneka, bivuze ko bishobora guhenda cyane udafite ubwishingizi.

Inshuti zimwe na zimwe zishobora gusaba uruhushya mbere yo gutanga Praluent, kandi muganga wawe ashobora gukenera kwerekana ko izindi miti igabanya cholesterol itagize icyo ikora kuri wowe.

Uburyo bwo gusimbuza Alirocumab

Niba alirocumab atagukwiriye, hari ubundi buryo butandukanye bushobora kugufasha kugenzura urwego rwa cholesterol yawe. Evolocumab (Repatha) ni indi PCSK9 inhibitor ikora kimwe na alirocumab ariko ishobora kwihanganirwa neza n'abantu bamwe.

Imiti ya statin ya gakondo nka atorvastatin (Lipitor) cyangwa rosuvastatin (Crestor) iracyakoreshwa nk'umuti wa mbere ku bantu benshi bafite cholesterol nyinshi. Iyi miti yo kunywa muri rusange irakora kandi ihendutse cyane kurusha PCSK9 inhibitors.

Izindi nshuti zirimo ezetimibe (Zetia), ibuza imitsi ya cholesterol mu mara yawe, na bile acid sequestrants nka cholestyramine. Ku bantu bafite triglycerides nyinshi cyane, imiti nka icosapent ethyl (Vascepa) ishobora kugira akamaro.

Uburyo bushya burimo bempedoic acid (Nexletol) na inclisiran (Leqvio), bikora binyuze mu buryo butandukanye bwo kugabanya cholesterol. Muganga wawe azagufasha kubona uruvange rwiza rw'imiti ishingiye ku byo ukeneye n'uko ubuzima bwawe buteye.

Ese Alirocumab iruta Evolocumab?

Alirocumab na evolocumab byombi ni ibinini bya PCSK9 bikora kimwe kandi bifite ubushobozi bungana mu kugabanya urugero rwa kolesteroli. Ubushakashatsi bwerekana ko imiti yombi ishobora kugabanya LDL cholesterolho 50-60% cyangwa kurenza iyo yongerewe ku miti ya statin.

Guhitamo hagati yayo akenshi biterwa n'ibintu by'umuntu ku giti cye nk'uko imiti igira ingaruka ku mubiri, gahunda yo kuyifata, n'ubwishingizi. Alirocumab akenshi itangwa buri byumweru bibiri, mugihe evolocumab ishobora gutangwa buri byumweru bibiri cyangwa buri kwezi, bitewe n'urugero rwa dose.

Abantu bamwe bashobora kwihanganira imwe kurusha iyindi, kandi muganga wawe ashobora guhindura imiti niba ubonye ingaruka zayo. Byombi bifite uburyo bw'umutekano bungana, ariko uburyo umuntu abyakira burashobora gutandukana.

Igiciro n'ubwishingizi akenshi bigira uruhare runini mu gufata icyemezo, kuko imiti yombi ihenze. Muganga wawe n'umufarumasiti bashobora kugufasha gukemura ibi bibazo bifatika mugihe bafasha ko ukoresha imiti igabanya kolesteroli neza.

Ibibazo Bikunze Kubazwa Kuri Alirocumab

Ese Alirocumab irakwiriye abantu barwaye diyabete?

Yego, alirocumab muri rusange irakwiriye abantu barwaye diyabete kandi ishobora kuba ingirakamaro cyane kuko diyabete yongera ibyago byo kurwara indwara z'umutima. Ubushakashatsi bwerekana ko alirocumab itagira ingaruka zigaragara ku rugero rw'isukari mu maraso, bigatuma iba uburyo bwiza ku barwayi ba diyabete bakeneye gukoresha imiti igabanya kolesteroli cyane.

Abantu barwaye diyabete akenshi bagira ibintu byinshi byongera ibyago byo kurwara indwara z'umutima, kandi ingaruka zikomeye zo kugabanya kolesteroli za alirocumab zishobora gufasha kugabanya ibyago byabo byose byo kurwara indwara z'umutima. Muganga wawe azagenzura urugero rwa kolesteroli yawe n'isukari mu maraso buri gihe kugirango yemeze ko uburyo bwo kuvura ibibazo byombi bukora neza.

Ninkora iki niba nifashishije alirocumab nyinshi bitunguranye?

Niba witewe alirocumab nyinshi kurusha uko byategetswe, vugana n'umuganga wawe cyangwa ikigo gishinzwe imiti ihumanya ako kanya. Nubwo kwirenza urugero kuri iyi miti bidakunze kubaho, ni ngombwa kubona inama z'inzobere ku byo gukora bikurikira.

Ntugerageze "gushyira mu gaciro" kwirenza urugero wirinda urugero rukurikira. Ahubwo, kurikiza amabwiriza ya muganga wawe yerekeye igihe cyo gusubukura gahunda yawe isanzwe yo gufata imiti. Bika neza ishashi y'umuti igihe uhamagaye kugira ngo ubone ubufasha, kuko iyi makuru izaba ingirakamaro ku baganga.

Nkwiriye gukora iki niba nciwe urugero rwa Alirocumab?

Niba wibagiwe urugero rwa alirocumab rwari rutegetswe, wiyitere ako kanya wibuka, igihe cyose kitarenze iminsi irindwi uvuye ku rugero wibagiwe. Hanyuma komeza gahunda yawe isanzwe y'ibyumweru bibiri kuva icyo gihe.

Niba iminsi irenze irindwi ishize uvuye ku rugero wibagiwe, rwirengagize rwose hanyuma utegere urugero rwawe rukurikira rutegetswe. Ntukongereho urugero kugira ngo wuzuze urwo wibagiwe, kuko ibi bishobora kongera ibyago byo kugira ingaruka ziterwa n'imiti.

Nshobora guhagarika ryari gufata Alirocumab?

Ugomba guhagarika gufata alirocumab gusa ubikore ubisabwe na muganga wawe. Cholesterol nyinshi akenshi ni indwara idakira isaba kuvurwa buri gihe, kandi guhagarika imiti bishobora gutuma urugero rwa cholesterol yawe ruzamuka mu byumweru bike.

Muganga wawe ashobora gutekereza guhagarika cyangwa kugabanya urugero niba urugero rwa cholesterol yawe rwaragenzurwaga neza igihe kirekire kandi izindi mpamvu zongera ibyago zarushijeho kuba nziza. Ariko, iki cyemezo kigomba gufatwa buri gihe hamwe n'umuganga wawe hashingiwe ku miterere yawe bwite.

Nshobora kugenda mfite Alirocumab?

Yego, urashobora kugenda ufite alirocumab, ariko bisaba gutegura kuko imiti ikenera gukonjesha. Mugihe ugenda mu ndege, uyitware mu gikapu cyawe cyo mu ntoki hamwe n'icyapa cy'urwandiko rwa muganga wawe rusobanura impamvu yo gukenera iyo miti.

Ku ngendo ndende, tekereza gukoresha agasanduku gakonjesha kavura gakozwe kubera imiti y'urushinge. Umuti urashobora kuba ku bushyuhe busanzwe kugeza ku minsi 30, ariko ni byiza kuwubika muri firigo igihe bibaye ngombwa kugirango ugumane ubushobozi bwawo.